ACE and myocardial infarction: In human patients, ventricular remodeling still occurs in around 30% of human myocardial infarcts despite timely primary coronary intervention and optimal standard pharmacotherapy (e.g. angiotensin-converting enzyme inhibitors (ACE-I), β-blockers, etc.)32.